Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PES
2826
DELISTED
Pioneer Energy Services Corp.
PES
| $400K | ﹤0.01% |
195,198
+53,900
| +38% | +$155K |
|
2827
Lineage Cell Therapeutics
LCTX
$257M
| $396K | ﹤0.01% |
143,569
+22,614
| +19% | +$63.2K |
|
|
HFBC
2828
DELISTED
HopFed Bancorp Inc
HFBC
| $393K | ﹤0.01% |
27,400
-2,000
| -7% | -$29.1K |
|
|
MICR
2829
DELISTED
Micron Solutions, Inc.
MICR
| $391K | ﹤0.01% |
100,200
+3,000
| +3% | +$12.1K |
|
2830
Sensata Technologies
ST
$6.75B
| $389K | ﹤0.01% |
9,100
-303,100
| -97% | -$12.5M |
|
2831
Delek Logistics
DKL
$3.03B
| $388K | ﹤0.01% |
11,849
-22,071
| -65% | -$693K |
|
|
AFI
2832
DELISTED
Armstrong Flooring, Inc.
AFI
| $388K | ﹤0.01% |
21,600
+2,600
| +14% | +$48.7K |
|
|
TLGT
2833
DELISTED
Teligent, Inc
TLGT
| $387K | ﹤0.01% |
4,230
+1,696
| +67% | +$144K |
|
2834
Eagle Bancorp Montana
EBMT
$187M
| $386K | ﹤0.01% |
21,300
+5,300
| +33% | +$99.4K |
|
2835
Monolithic Power Systems
MPWR
$65.8B
| $386K | ﹤0.01% |
4,000
-300
| -7% | -$28.6K |
|
|
NBSE
2836
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $373K | ﹤0.01% |
1,458
+884
| +154% | +$237K |
|
|
CYAN
2837
DELISTED
Cyanotech Corp
CYAN
| $373K | ﹤0.01% |
105,000
+1,400
| +1% | +$5.17K |
|
|
SLCT
2838
DELISTED
Select Bancorp, Inc.
SLCT
| $373K | ﹤0.01% |
30,547
-153
| -0.5% | -$1.78K |
|
2839
Eldorado Gold
EGO
$8.48B
| $371K | ﹤0.01% |
+28,140
| New | +$459K |
|
|
TCS
2840
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $371K | ﹤0.01% |
4,173
-1,740
| -29% | -$125K |
|
|
NXTM
2841
DELISTED
NxStage Medical Inc.
NXTM
| $371K | ﹤0.01% |
14,783
-132,200
| -90% | -$3.27M |
|
|
VRML
2842
DELISTED
Vermillion, Inc.
VRML
| $370K | ﹤0.01% |
201,200
-48,700
| -19% | -$89K |
|
2843
Eledon Pharmaceuticals
ELDN
$276M
| $367K | ﹤0.01% |
3,488
+950
| +37% | +$96.8K |
|
2844
vTv Therapeutics
VTVT
$122M
| $367K | ﹤0.01% |
1,847
+252
| +16% | +$52.5K |
|
|
CMBT
2845
CMB.TECH NV
CMBT
$4.46B
| $367K | ﹤0.01% |
46,400
+10,300
| +29% | +$79.4K |
|
|
MMAC
2846
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $367K | ﹤0.01% |
16,062
-5,900
| -27% | -$137K |
|
|
BOJA
2847
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $367K | ﹤0.01% |
22,600
-114,300
| -83% | -$2.11M |
|
|
KRA
2848
DELISTED
Kraton Corporation
KRA
| $365K | ﹤0.01% |
10,600
-320,700
| -97% | -$10.5M |
|
2849
Centrus Energy
LEU
$3.46B
| $364K | ﹤0.01% |
85,967
-16,933
| -16% | -$84.7K |
|
|
FAC
2850
DELISTED
First Acceptance Corp.
FAC
| $364K | ﹤0.01% |
319,600
+5,700
| +2% | +$6.78K |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.